AEGLE MEDICAL

• 21200 - Manufacture of pharmaceutical preparations
• 72110 - Research and experimental development on biotechnology

Aegle Medical Ltd. believes that information about our customers, business partners and suppliers is their property and is not "data" to be used or shared without their agreement. We hold ourselves to the highest standards of data privacy and protection and will never knowingly share information without consent... Our senior management team has prior experience in setting up and funding new businesses and provides expertise in rapidly scaling teams and processes... Age Related Macular Degeneration (AMD) is a chronic disease that gradually destroys the retina, is the innermost, light-sensitive layer of tissue of the eye. It is a common condition effecting humans as well as both dogs and cats, which reduces visual acuity. Our product, LuCeria, is a colloidal suspension for use in the treatment of a disorder or disease of the posterior segment of the eye. The treatment comprises administration of a topical ophthalmic dose of the colloidal suspension.

Also known as: AEGLE BIOMEDICAL LTD, Aegle Medical Ltd.

Registration numbers: 14255074 (CH)

Primary location: London United Kingdom